Janadi Ashinshani Karawita
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Janadi Ashinshani Karawita has a total of 14 co-authors. Here are the top co-authors by number of shared publications:
- Adnan Akhtar Shaikh
Faculty of Medicine, Tbilisi State Medical University, Tbilisi 0186, Georgia
1 shared publication - Afra Wasama Islam
Faculty of Medicine, Tbilisi State Medical University, Tbilisi 0160, Georgia
1 shared publication - Aliya Modak
Tbilisi State Medical University
1 shared publication - Arun Venkiteswaran
Tbilisi State Medical University
1 shared publication - Faiza Yasmine Kabachi
Tbilisi State Medical University
1 shared publication - Felcia Reji
Faculty of Medicine, Tbilisi State Medical University, Tbilisi 0186, Georgia
1 shared publication
Latest Publications
- 25 August 2025
- Published by Taylor & Francis in Expert Review of Clinical Immunology
- Vol. 21 (9) , 1287-1295
Assessing Atopic Dermatitis severity in children from Georgia: the correlation of inflammatory blood markers to the Eczema Area and Severity Index
Atopic dermatitis (AD) is a chronic inflammatory skin condition prevalent among children worldwide. Systemic inflammation is a key factor in its pathophysiology. Correlating blood markers with Eczema Area and Severity Index (EASI) can reveal information about the severity and activity of the disorder, allowing for more focused treatment. A retrospective analysis was conducted on 22 patients aged 3 months to 18 years. Blood parameters, such as Eosinophil Relative Count (ERC), Neutrophil/Lymphocyte Ratio (NLR), Eosinophil/Lymphocyte Ratio (ELR), and Basophil/Lymphocyte Ratio (BLR), were correlated with the Eczema Area and Severity Index (EASI). A strong positive correlation was observed between EASI scores and ERC (r = 0.69, p < 0.001) and with ELR (r = 0.71, p < 0.001). No statistical significance was seen between EASI scores and the NLR (r = 0.2059, p = 0.3578) and BLR (r = 0.1026, p = 0.6494). No significant association was found between age and EASI scores (r = -0.0351, p = 0.8767). ERC and ELR have the potential to serve as objective blood markers for assessing AD severity. However, more research in pediatric populations with a larger sample size is needed to establish a conclusive association for clinical practice.
- 25 August 2025
- Published by Taylor & Francis in Expert Review of Clinical Immunology
- Vol. 21 (9) , 1287-1295
Assessing Atopic Dermatitis severity in children from Georgia: the correlation of inflammatory blood markers to the Eczema Area and Severity Index
Atopic dermatitis (AD) is a chronic inflammatory skin condition prevalent among children worldwide. Systemic inflammation is a key factor in its pathophysiology. Correlating blood markers with Eczema Area and Severity Index (EASI) can reveal information about the severity and activity of the disorder, allowing for more focused treatment. A retrospective analysis was conducted on 22 patients aged 3 months to 18 years. Blood parameters, such as Eosinophil Relative Count (ERC), Neutrophil/Lymphocyte Ratio (NLR), Eosinophil/Lymphocyte Ratio (ELR), and Basophil/Lymphocyte Ratio (BLR), were correlated with the Eczema Area and Severity Index (EASI). A strong positive correlation was observed between EASI scores and ERC (r = 0.69, p < 0.001) and with ELR (r = 0.71, p < 0.001). No statistical significance was seen between EASI scores and the NLR (r = 0.2059, p = 0.3578) and BLR (r = 0.1026, p = 0.6494). No significant association was found between age and EASI scores (r = -0.0351, p = 0.8767). ERC and ELR have the potential to serve as objective blood markers for assessing AD severity. However, more research in pediatric populations with a larger sample size is needed to establish a conclusive association for clinical practice.
- 25 March 2025
- Published by Springer Nature in Current Dermatology Reports
- Vol. 14 (1) , 1-16
Advances in Botulinum Toxin Applications: Enhancing Wound Healing and Optimizing Scar Management
- 25 March 2025
- Published by Springer Nature in Current Dermatology Reports
- Vol. 14 (1) , 1-16
Advances in Botulinum Toxin Applications: Enhancing Wound Healing and Optimizing Scar Management
- Open Access
- 10 February 2025
- Published by Open Exploration Publishing
- Vol. 3, 101250
Comparison of short-term and long-term effects of peroral L-carnitine intake: clinical implications of elevated TMAO levels in cardiovascular complications
L-Carnitine (LC) is integral to energy production and fatty acid metabolism, facilitating the transport of long-chain fatty acids into mitochondria for β-oxidation. It modulates metabolic pathways, including pyruvate dehydrogenase activity, proteolysis, and protein synthesis, while also having anti-inflammatory and antioxidant characteristics. LC can be commonly applied to win the battle against HIV and cancer cachexia. Also, it can be recruited with the aim of improving physical and cognitive functions in athletes and the elderly. Despite these benefits, long-term LC administration has been associated to cardiovascular risks due its conversion to trimethylamine-N-oxide (TMAO) by the gut microbiota. Elevated TMAO levels are linked to atherosclerosis, oxidative stress, and an increased risk of cardiovascular disease, diabetes, and chronic kidney disease. Managing TMAO levels using dietary treatments and gut microbiota-targeting techniques, such as probiotics, may reduce these risks. This comprehensive review presents the state-of-the-art information on LC’s dual role, emphasizing the balance between its therapeutic potential and the risks of prolonged supplementation. It aims to guide clinicians and researchers in optimizing LC’s benefits while addressing its long term cardiovascular safety concerns.
- 10 February 2025
- Published by Open Exploration Publishing
- Vol. 3, 101250
Open AccessComparison of short-term and long-term effects of peroral L-carnitine intake: clinical implications of elevated TMAO levels in cardiovascular complications
L-Carnitine (LC) is integral to energy production and fatty acid metabolism, facilitating the transport of long-chain fatty acids into mitochondria for β-oxidation. It modulates metabolic pathways, including pyruvate dehydrogenase activity, proteolysis, and protein synthesis, while also having anti-inflammatory and antioxidant characteristics. LC can be commonly applied to win the battle against HIV and cancer cachexia. Also, it can be recruited with the aim of improving physical and cognitive functions in athletes and the elderly. Despite these benefits, long-term LC administration has been associated to cardiovascular risks due its conversion to trimethylamine-N-oxide (TMAO) by the gut microbiota. Elevated TMAO levels are linked to atherosclerosis, oxidative stress, and an increased risk of cardiovascular disease, diabetes, and chronic kidney disease. Managing TMAO levels using dietary treatments and gut microbiota-targeting techniques, such as probiotics, may reduce these risks. This comprehensive review presents the state-of-the-art information on LC’s dual role, emphasizing the balance between its therapeutic potential and the risks of prolonged supplementation. It aims to guide clinicians and researchers in optimizing LC’s benefits while addressing its long term cardiovascular safety concerns.